Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1388-1391

  Prezant, Toni R ^a   Levine, Jonathan ^a   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ADENOHYPOPHYSIS DISEASE; ARTICLE; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0031732536     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.4.4859     Document Type: Article

References (19)

1. Greenman Y and Melmed S 1996 Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med 47: 95-106.
2. Alexander JM, Biller BMK, Bikkal H et al. 1990 Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336-340.
3. Herman V, Fagin J, Gonsky R, et al. 1990 Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427-1433.
4. Shimon I and Melmed S 1997 Genetic Basis of Endocrine Disease. Pituitary Tumor Pathogenesis. J Clin Endocrinol Metab 82:1675-1681.
5. Thakker RV, Pook MA, Wooding C, et al 1993 Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91: 2815-2821.
6. Larsson C, Skogseid B, Oberg K, et al. 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85-87.
7. Bates AS, Farrell WE, Bicknell EJ, et al. 1997 Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82: 818-824.
8. Knudson AG, Jr. 1971 Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823.
9. Chandrasekharappa SC, Guru SC, Manickam P, et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-407.
10. Heppner C, Kester MB, Agarwal SK, et al. 1997 Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16: 375-378.
11. Zhuang Z, Vortmeyer AO, Pack S, et al. 1997 Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res. 57:4682-4686.
12. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968-1972.
13. Eubanks PJ, Sawicki MP, Samara GJ, et al. 1994 Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. Am J Surgery 167: 180-185.
14. Larsson C, Calender A, Grimmond S, et al. 1995 Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J Int Med 238: 239-244.
15. Manickam P, Guru S, Debelenko LV, et al. 1997 Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet. 101:102-108.
16. Prezant TR, Agapian JV, Bohlman MC, et al. 1993 Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet 4: 289-294.
17. Agarwal SK, Kester MB, Debelenko LV, et al. 1997 Germline mutations of the men1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 7: 1169-1175.
18. Zhuang Z, Ezzat SZ, Vortmeyer AO, et al. 1997 Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 57:5446-5451.
19. Futreal PA, Liu Q, Shattuck-Eidens D, et al. 1994 BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122.